An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
Public ClinicalTrials.gov record NCT02316847. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-center, Open-label, Study of Safety and Tolerability of Chronic Intermittent Usage of Diazepam Nasal Spray in Adolescents and Adult Patients With Cluster Seizures, Including Assessment of Olfaction and Reported Changes in Taste.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess long-term safety and tolerability of repeat dose diazepam nasal spray in adolescents and adults with cluster seizures, with a focus on potential local effects (changes in nasal mucosa, olfaction, and taste).
Study identification
- NCT ID
- NCT02316847
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2014 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Sep 2016 (Actual)
- Last update posted
- Jul 30, 2018
2014 – 2016
United States locations
- U.S. sites
- 33
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acorda Site #227 | Phoenix | Arizona | 85054 | — |
| Acorda Site #204 | Little Rock | Arkansas | 72205 | — |
| Acorda Site #213 | Los Angeles | California | 90095 | — |
| Acorda Site #220 | Orange | California | 92868 | — |
| Acorda Site #206 | Orlando | Florida | 32819 | — |
| Acorda Site #241 | Port Charlotte | Florida | 33592 | — |
| Acorda Site #231 | Tallahassee | Florida | 32308 | — |
| Acorda Site #201 | Tampa | Florida | 33606 | — |
| Acorda Site #234 | Tampa | Florida | 33609 | — |
| Acorda Site #217 | Augusta | Georgia | 30912 | — |
| Acorda Site #232 | Honolulu | Hawaii | 96817 | — |
| Acorda Site #225 | Fort Wayne | Indiana | 46804 | — |
| Acorda Site #226 | Ames | Iowa | 50010 | — |
| Acorda Site #202 | Bethesda | Maryland | 20817 | — |
| Acorda Site #212 | Boston | Massachusetts | 02115 | — |
| Acorda Site #214 | Boston | Massachusetts | 02115 | — |
| Acorda Site #208 | Boston | Massachusetts | 02215 | — |
| Acorda Site #216 | Kansas City | Missouri | 64111 | — |
| Acorda Site #205 | St Louis | Missouri | 63131 | — |
| Acorda Site #222 | Hackensack | New Jersey | 07601 | — |
| Acorda Site #223 | New York | New York | 10016 | — |
| Acorda Site #233 | Rochester | New York | 14642 | — |
| Acorda Site #230 | Portland | Oregon | 97239 | — |
| Acorda Site #219 | Philadelphia | Pennsylvania | 19104 | — |
| Acorda Site #237 | Philadelphia | Pennsylvania | 19107 | — |
| Acorda Site #203 | Charleston | South Carolina | 29425 | — |
| Acorda Site #235 | Memphis | Tennessee | 38103 | — |
| Acorda Site #218 | Nashville | Tennessee | 37232 | — |
| Acorda Site #221 | Dallas | Texas | 75251 | — |
| Acorda Site #229 | Houston | Texas | 77030 | — |
| Acorda Site #215 | Richmond | Virginia | 23298 | — |
| Acorda Site #224 | Renton | Washington | 98057 | — |
| Acorda Site #210 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02316847, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2018 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02316847 live on ClinicalTrials.gov.